Analyst Information
Tyler Van BurenSr. Research Analyst![]() Tyler Van Buren is a managing director and senior research analyst at Piper Sandler covering biotechnology companies. Prior to joining Piper Sandler in 2018, Van Buren spent five years at Cowen and Company, where he covered large and smid-cap biopharma companies. In 2017, Institutional Investor recognized Van Buren as the No. 1 Rising Star in the specialty pharma category and the No. 2 Rising Star across therapeutics. Previously, Van Buren was a founding member and managing director at New York-based LifeSci Advisors where he helped build the firm’s biotechnology research practice. Earlier in his career, he worked at Amylin Pharmaceuticals, Lithera Pharmaceuticals, the Sanford-Burnham Medical Research Institute and the U.S. Department of Agriculture. Van Buren earned a master’s degree in biology and a bachelor’s degree in biochemistry and cellular biology from the University of California, San Diego. |
Universe Coverage: Healthcare: Biotechnology | |
ADVM | Adverum Biotechnologies, Inc. |
AGIO | Agios Pharmaceuticals, Inc. |
AKUS | Akouos, Inc. |
ALGS | Aligos Therapeutics, Inc. |
ALLO | Allogene Therapeutics, Inc. |
APTO | Aptose Biosciences, Inc. |
BGNE | BeiGene Ltd. |
BCRX | BioCryst Pharmaceuticals, Inc. |
BHVN | Biohaven Pharmaceutical Holding Company Ltd |
BLUE | bluebird bio, Inc. |
BBIO | BridgeBio Pharma, Inc. |
CBIO | Catalyst Biosciences, Inc. |
CRNX | Crinetics Pharmaceuticals, Inc. |
EPIX | ESSA Pharma, Inc. |
GILD | Gilead Sciences, Inc. |
GOSS | Gossamer Bio |
GRCL | Gracell Biotechnologies Inc. |
HARP | Harpoon Therapeutics, Inc. |
INCY | Incyte Corporation |
INZY | Inozyme Pharma, Inc. |
IONS | Ionis Pharmaceuticals, Inc. |
KNTE | Kinnate Biopharma, Inc. |
KRON | Kronos Bio, Inc. |
KURA | Kura Oncology, Inc. |
LPTX | Leap Therapeutics, Inc. |
MGTX | MeiraGTx Holdings Plc |
MRTX | Mirati Therapeutics, Inc. |
NKTR | Nektar Therapeutics |
NLTX | Neoleukin Therapeutics, Inc. |
NRIX | Nurix Therapeutics, Inc. |
OTIC | Otonomy, Inc. |
OYST | Oyster Point Pharma, Inc. |
PLRX | Pliant Therapeutics, Inc. |
PSTX | Poseida Therapeutics, Inc. |
PRAX | Praxis Precision Medicines, Inc. |
RCKT | Rocket Pharmaceuticals, Inc. |
SRPT | Sarepta Therapeutics, Inc. |
TCRR | TCR2 Therapeutics |